Clinical trials in Fayetteville, AR

16 recruiting studies have a site in or near Fayetteville, AR, Arkansas.

Top conditions here

All conditions

Showing 16 of 16 studies

RecruitingPhase 3NCT06629779

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Sponsor: Pfizer

Fayetteville, AR · Little Rock, AR · Rogers, AR · +36 more sites

RecruitingPhase 3NCT07028853

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Sponsor: Pfizer

Fayetteville, AR · Rogers, AR · Springdale, AR · +124 more sites

RecruitingPhase 2NCT06656416

ALTO-100 in Bipolar Disorder With Depression (BD-D)

Sponsor: Alto Neuroscience

Fayetteville, AR · Little Rock, AR · +55 more sites

RecruitingPhase 3NCT07144280

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Sponsor: Pfizer

Fayetteville, AR · Rogers, AR · Springdale, AR · +238 more sites

RecruitingPhase 3NCT06810505

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Sponsor: AbbVie

Fayetteville, AR · Little Rock, AR · +30 more sites

RecruitingPhase 3NCT07222566

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Sponsor: Pfizer

Fayetteville, AR · Rogers, AR · Springdale, AR · +223 more sites

RecruitingPhase 3NCT07222800

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Sponsor: Pfizer

Fayetteville, AR · Rogers, AR · Springdale, AR · +251 more sites

RecruitingPhase 1 / Phase 2NCT07181161

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Sponsor: AstraZeneca

Fayetteville, AR · +10 more sites

RecruitingPhase 3NCT05939414

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Sponsor: Novartis Pharmaceuticals

Fayetteville, AR · +38 more sites

RecruitingPhase not listedNCT04994015

Parkinson's Foundation PD GENEration Genetic Registry

Sponsor: Parkinson's Foundation

Fayetteville, AR · +62 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Fayetteville, AR · Jonesboro, AR · Little Rock, AR · +825 more sites

RecruitingPhase 1NCT04389632

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Fayetteville, AR · Rogers, AR · Springdale, AR · +103 more sites

RecruitingNot applicableNCT06740162

Physical Activity and Community EmPOWERment Project

Sponsor: University of North Carolina, Chapel Hill

Fayetteville, AR · +1 more sites

RecruitingPhase 3NCT06470243

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Sponsor: SWOG Cancer Research Network

Fayetteville, AR · Rogers, AR · Springdale, AR · +171 more sites

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Fayetteville, AR · Fort Smith, AR · Jonesboro, AR · +952 more sites

RecruitingNot applicableNCT04949451

Time Restricted Feeding, Muscle, and Metabolism

Sponsor: University of Arkansas, Fayetteville

Fayetteville, AR

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.